SLC3A2 and Miyoshi myopathy: MM patients with high levels of SLC3A2 or SLC7A5 protein expression by immunohistological staining had inferior progression-free survival25, and a recent study found that SLC3A2 and SLC7A5 were among the most abundant proteins on the surface of MM cells50.